Insights and Stories on Monsanto

Apr. 13, 2017 at 12:38 pm CDT

London | Reuters — Results of a new animal study into possible health risks of glyphosate will be published in time to inform a key EU re-licensing vote due by the end of 2017, according to the researcher leading the trial. A row over possible effects of glyphosate — an […]

By Kate Kelland

Mar. 27, 2017 at 2:23 pm CDT

Brussels | Reuters — A majority of EU countries voted on Monday against allowing two new genetically modified crops to be grown in Europe, batting the contentious decision on GM cultivation in Europe back to the EU executive. EU governments were asked to vote on the future of two grades […]

By Reuters

Mar. 15, 2017 at 1:28 pm CDT

Helsinki | Reuters — Glyphosate, the key ingredient in Monsanto’s Roundup herbicide, should not be classified as a substance causing cancer, the European Chemical Agency concluded on Wednesday, potentially paving the way for its licence renewal in the EU. A transatlantic row over possible risks to human health has prompted […]

By Jussi Rosendahl, Tuomas Forsell

Mar. 14, 2017 at 11:45 pm CDT

Reuters — Employees of Monsanto ghostwrote scientific reports that U.S. regulators relied on to determine that a chemical in its Roundup herbicide does not cause cancer, farmers and others suing the company claimed in court filings. The documents, made public Tuesday, are part of a mass litigation in federal court […]

By Brendan Pierson

Mar. 10, 2017 at 7:00 pm CST

Frankfurt | Reuters — German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly US$2.5 billion as they seek regulatory clearance for their US$66 billion merger, people close to the matter said. To kick off an auction process, Bayer’s advisors will send […]

By Reuters